Feature
Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D
-
By
-
February 25, 2026
-
9 min
-
1
iPSC-derived models enable early insights in drug discovery.
-
2
They preserve patient-specific genetic information.
-
3
Standardization improves data comparability.
-
4
Project Mosaic aims to reflect ALS patient heterogeneity.
-
5
iPSC models facilitate understanding complex diseases.
-
6
Organ IDs improve preclinical efficiency.
-
7
iPSC technology is expanding beyond rare diseases.
-
8
Relevant patient-derived biology enhances decision-making in drug development.
